Browsing by Author Sogaard, Ole Schmeltz

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 5 of 5
Issue DateTitleAuthor(s)Citation
2018Genetic characterization of the HIV-1 reservoir after Vacc-4x and romidepsin therapy in HIV-1 infected individualsMorcilla, Vincent; Palmer, Sarah; Schlub, Timothy; Winckelmann, Anni; Benton, Paul; Hojen, Jesper; Ostergaard, Lars; Schleimann, Mariane; Shao, Wei; Sogaard, Ole Schmeltz; Tolstrup, Martin; Westmead Clinical School: Westmead Institute for Medical Res; Westmead Clinical School: Westmead Institute for Medical Res; Central Clinical School: Medicine; Westmead Clinical School: Westmead Institute for Medical ResGenetic characterization of the HIV-1 reservoir after Vacc-4x and romidepsin therapy in HIV-1 infected individuals, AIDS, vol.32, 13, 2018,pp 1793-1802
2015Innate immune activity correlates with CD4 T cell-associated HIV-1 DNA decline during latency-reversing treatment with panobinostatPalmer, Sarah; Bashirova, Arman; Brinkmann, Christel; Buzon, Maria; Carrington, Mary; et al, Various; Olesen, Rikke; Ouyang, Zhengyu; Rasmussen, Thomas; Sogaard, Ole Schmeltz; Vigano, Selena; Yu, Xu; Western Clinical School: Westmead Institute for Medical ResInnate immune activity correlates with CD4 T cell-associated HIV-1 DNA decline during latency-reversing treatment with panobinostat, Journal of Virology, vol.89, 20, 2015,pp 10176-10189
2014Panobinostat, a histone deacetylase inhibitor, for latent virus reactivation in HIV-infected patients on suppressive antiretroviral therapy: A phase 1/2, single group, clinical trialPalmer, Sarah; Brinkmann, Christel; Buzon, Maria; Dinarello, Charles A.; Erikstrup, Christian; Lewin, Sharon; Lichterfeld, Mathias; Olesen, Rikke; Ostergaard, Lars; Rasmussen, Thomas; Sogaard, Ole Schmeltz; Solomon, Ajantha; Tolstrup, Martin; Winckelmann, Anni A.; Western Clinical School: Westmead Millennium InstitutePanobinostat, a histone deacetylase inhibitor, for latent virus reactivation in HIV-infected patients on suppressive antiretroviral therapy: A phase 1/2, single group, clinical trial, The Lancet HIV, vol.1, 1, 2014,pp e13-e21
2017Romidepsin-induced HIV-1 viremia during effective antiretroviral therapy contains identical viral sequences with few deleterious mutationsBarton, Kirston; Hiener, Bonnie; Palmer, Sarah; Schlub, Timothy; Winckelmann, Anni; Ostergaard, Lars; Rasmussen, Thomas; Shao, Wei; Sogaard, Ole Schmeltz; Tolstrup, Martin; Western Clinical School: Westmead Institute for Medical Res; Western Clinical School: Westmead Institute for Medical Res; Western Clinical School: Westmead Institute for Medical Res; Central Clinical School: Medicine; Western Clinical School: Westmead Institute for Medical ResRomidepsin-induced HIV-1 viremia during effective antiretroviral therapy contains identical viral sequences with few deleterious mutations, AIDS, vol.31, 6, 2017,pp 771-779
2017Romidepsin-induced HIV-1 viremia during effective antiretroviral therapy contains identical viral sequences with few deleterious mutationsBarton, Kirston; Hiener, Bonnie; Palmer, Sarah; Schlub, Timothy; Winckelmann, Anni; Ostergaard, Lars; Rasmussena, Thomas; Shao, Wei; Sogaard, Ole Schmeltz; Tolstrup, Martin; Westmead Clinical School: Westmead Institute for Medical Res; Westmead Clinical School: Westmead Institute for Medical Res; Westmead Clinical School: Westmead Institute for Medical Res; Central Clinical School: Medicine; Westmead Clinical School: Westmead Institute for Medical ResRomidepsin-induced HIV-1 viremia during effective antiretroviral therapy contains identical viral sequences with few deleterious mutations, AIDS, vol.31, 6, 2017,pp 771-779